Australia markets open in 2 hours 12 minutes

Graybug Vision, Inc. (GRAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4800-0.0800 (-2.25%)
At close: 4:00PM EDT
3.5000 +0.02 (+0.57%)
After hours: 04:27PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.5600
Open3.5000
Bid3.4600 x 1100
Ask3.5200 x 800
Day's range3.4600 - 3.5600
52-week range3.0500 - 37.8800
Volume56,942
Avg. volume205,864
Market cap74.071M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Graybug Vision to Participate in the Annual Ophthalmology Innovation Summit (OIS) Retina@ASRS Conference

    BALTIMORE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will participate in the following events at the Ophthalmology Innovation Summit (OIS) Retina on Thursday, October 7, 2021, in San Antonio, Texas. The OIS Retina conference is being

  • GlobeNewswire

    Graybug Vision Reports Analysis of Data from the Six-Month Extension Study of the ALTISSIMO Phase 2b Trial in Wet AMD

    55% of GB-102 1mg patients in Extension Study experienced duration of 12+ months, while maintaining their visual acuity and central retinal thickness73% reduction of injection burden for patients participating in Extension StudyGB-102 1mg continued to indicate a favorable safety profile and was well-tolerated BALTIMORE, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatmen

  • GlobeNewswire

    Graybug Vision to Participate in the Cantor Virtual Global Healthcare Conference

    BALTIMORE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 11:20 a.m. ET / 8:20 a.m. PT. Dr. Guerard will provide a corporate update, in